Jazz Pharma Bets $175 Million on This Massachusetts Biotech's Antibody-Drug Program Post author:Sam Post published:August 28, 2017 Post category:BioPharma August 29, 2017By Alex Keown, BioSpace… Source: BioSpace You Might Also Like SoCal's Capricor to Reduce Workforce and Shift Focus After Discouraging Trial Results May 11, 2017 <b>Vividion Therapeutics</b> Launches With $50 Million and a Celgene Alum as Executive Chairman February 1, 2017 Reckitt CEO's $17B Predicament December 26, 2017
<b>Vividion Therapeutics</b> Launches With $50 Million and a Celgene Alum as Executive Chairman February 1, 2017
